Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated

Emily Feneberg1, Maximilian Gahr, Eik Baumgarten

  • 1Department of Psychiatry and Psychotherapy III and Department of Neurology, University of Ulm, Ulm, Germany emily.feneberg@uni-ulm.de Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany Department of Internal Medicine I, University of Ulm, Ulm, Germany Department of Neuroradiology, BKH-Günzburg, University of Ulm, Günzburg, Germany Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany.

The Journal of ECT
|May 23, 2015
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.2K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
785
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
676